Japanese cypress pollinosis
Conditions
Interventions
Determining threshold of skin test to Japanese cypress pollen extract in subjects having class 2 or more serum IgE specific for Japanese cypress pollen
Sponsors
Okano Mitsuhiro
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Japanese adults having serum IgE specific for Japanese cypress pollen equal or above class 2 2. Aged equal or more than 20 years old and less than 60 years old 3. Regardless of gender 4. Acquisition of written informed consent for participation on this clinical trial 5. Possible to visit hospital/clinic and follow
Exclusion criteria
Exclusion criteria: 1. Subjects using drugs such as antihistamine which may affect results of skin test at examination day 2. Subjects having disease on application site of skin test 3. Subjects having experience of Japanese cedar-specific allergen immunotherapy 4. Subjects having severe asthma 5. Subjects having uncontrolled allergic diseases 6. Subjects having experience of anaphylaxis 7. Subjects having experience of hypersensitivity to adrenalin 8. Subjects having heart, liver, kidney or blood diseases or infection which may affect the outcome of examination 9. Subjects with pregnancy or breastfeeding 10. Subjects who are judged inappropriate to participate in the trial by investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive reaction to skin tests | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation with serum IgE titer, adverse reactions | — |
Contacts
Public ContactYuko Kariya
International University of Health and Welfare Narita Hospital
Outcome results
None listed